Back to Conditions

Ropinirole: Restless Legs and Parkinson's

Ropinirole: Restless Legs and Parkinson's
Prescription Medicines Editorial 8 February 2026

Ropinirole is a dopamine agonist, stimulating dopamine receptors directly. It is used in Parkinson's disease and in restless legs syndrome. Everything that applies to pramipexole applies here - impulse control disorders, sudden onset of sleep, and augmentation in restless legs are class effects rather than properties of one drug. What is different is how it is cleared from the body, which produces an interaction most people would never guess at.

Follow the plan your prescriber gave you. This guide contains no doses. Do not stop it suddenly.

Impulse control disorders

Dopamine agonists can cause compulsive gambling, shopping, binge eating and hypersexuality, along with repetitive purposeless activity.

These are dose-related effects of stimulating dopamine reward pathways. They affect a meaningful proportion of people taking these drugs, and they usually resolve when the medicine is reduced or stopped.

The difficulty is that the person affected does not experience it as a side effect. Savings are lost and relationships end before anyone connects it to a tablet for restless legs.

Anyone starting a dopamine agonist should be told about this, and so should the people they live with - a family member usually notices first. If you have seen new gambling, spending, eating or sexual behaviour since starting, report it. It is a medical problem with a medical solution.

Our guide to pramipexole covers this in more detail.

Sudden onset of sleep

Excessive daytime sleepiness is common, and some people experience sleep attacks without warning - including while driving, and in some cases without feeling drowsy beforehand.

You must inform the DVLA if you have excessive sleepiness, and you must not drive if you have had any episode of sudden sleep. See medicines and driving.

The smoking and caffeine interaction

This is what distinguishes ropinirole practically. It is cleared by the CYP1A2 enzyme, which is induced by tobacco smoke and inhibited by several other things.

The consequences are genuinely counter-intuitive:

  • Stopping smoking raises ropinirole levels, potentially causing nausea, dizziness and drowsiness weeks after the dose last changed. It is a reason to review the dose when someone quits - and it is almost never mentioned in smoking cessation.
  • Starting smoking lowers levels, reducing effect.
  • Ciprofloxacin strongly inhibits the same enzyme and substantially raises ropinirole levels. A course of antibiotics for a urinary infection can make someone with Parkinson's markedly unwell - see doxycycline for alternatives in that family.
  • Oestrogen, including in HRT, affects levels too.

Caffeine is metabolised by the same enzyme, so intake changes can matter - see caffeine and your medicines.

Pramipexole is cleared by the kidneys instead, so it does not share any of this - which is occasionally a reason to choose between them.

In restless legs

Ropinirole is effective for restless legs, but the class carries a specific long-term problem: augmentation.

Augmentation means the condition worsens on treatment - symptoms start earlier in the day, become more intense, and spread to the arms. It is caused by the treatment, and increasing the dose makes it worse.

Because of this, guidance has moved away from dopamine agonists as first choice for restless legs, favouring alpha-2-delta ligands such as gabapentin or pregabalin - see pregabalin.

Check iron first. Low ferritin is a common, treatable cause of restless legs and correcting it can remove the need for any of this - see iron tablets.

In Parkinson's disease

Used alone in earlier disease or alongside levodopa later. Starting with an agonist in younger patients delays some of the movement complications of long-term levodopa.

It treats symptoms; it does not slow the disease.

Avoid dopamine-blocking anti-sickness medicines - prochlorperazine and metoclopramide will worsen Parkinson's markedly. This is a common and avoidable error when someone with Parkinson's presents with nausea. See prochlorperazine and metoclopramide.

Other side effects

Nausea, dizziness on standing, headache, swollen ankles and constipation. Hallucinations and confusion occur, more often in older people and in advanced disease.

The dose is built up slowly to limit nausea and dizziness.

Levodopa and the longer game

Where a dopamine agonist is used first in Parkinson's, levodopa is usually added later as symptoms progress. Agonists are less effective than levodopa but cause fewer of the involuntary movements that develop with long-term levodopa use.

The strategy is therefore about sequencing rather than about one drug being better. In older people levodopa is often started first, because the hallucinations, confusion and impulse effects of agonists are more likely and more damaging with age.

Do not stop suddenly

Abrupt withdrawal can cause a dopamine agonist withdrawal syndrome - anxiety, panic, depression, sweating, pain and craving - which can be severe and prolonged. In Parkinson's it also risks serious deterioration.

Reduction is planned and gradual. Running out counts as stopping - see ordering repeats and why you cannot just stop some medicines.

Modified-release tablets must be swallowed whole, and immediate and modified-release forms are not interchangeable - see cutting and crushing tablets.

The Conditions section covers more on what medicines are prescribed for - Timolol Eye Drops: The Beta Blocker in Your Eye is closely related to this one.